Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mortimer Poncz

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Transcription Factor RUNX1 Regulates Coagulation Factor XIII-A ( <i>F13A1</i> ): Decreased Platelet-Megakaryocyte <i>F13A1</i> Expression and Clot Contraction in <i>RUNX1</i> HaplodeficiencyFabiola Del Carpio-Cano, Natthapol Songdej, Liying Guan, et al.
Blood|February 21, 2020
Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagationIan Johnston, Amrita Sarkar, Vincent Hayes, et al.
Blood|July 15, 2016
The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)Sanjay Khandelwal, Grace M Lee, C Garren Hester, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Modulation of ultralarge immune complexes in heparin-induced thrombocytopeniaZheng Cai, Khalil Bdeir, Serge V Yarovoi, et al.
The Journal of Biological Chemistry|December 6, 2002
Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cellsTaher Nassar, Bruce S Sachais, Sa'ed Akkawi, et al.
Blood|June 17, 2020
RGS10 and RGS18 differentially limit platelet activation, promote platelet production, and prolong platelet survivalDaniel DeHelian, Shuchi Gupta, Jie Wu, et al.
Blood|April 21, 2026
PF4/Heparin-Nonbinding Platelet-Activating Antibodies in Heparin-Induced ThrombocytopeniaLu Zhou, Andrew Cao, Wen Zhu, et al.
Blood Advances|March 31, 2018
2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopeniaElizabeth Tkaczynski, Abinaya Arulselvan, John Tkaczynski, et al.
Blood Advances|May 17, 2023
Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?Amrita Sarkar, Sanjay Khandelwal, Gavin T Koma, et al.
Nature Communications|January 23, 2020
Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasisBrian D Adair, José L Alonso, Johannes van Agthoven, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
Medrxiv : the Preprint Server for Health Sciences|January 7, 2025
Transcription Factor RUNX1 Regulates Coagulation Factor XIII-A ( <i>F13A1</i> ): Decreased Platelet-Megakaryocyte <i>F13A1</i> Expression and Clot Contraction in <i>RUNX1</i> HaplodeficiencyFabiola Del Carpio-Cano, Natthapol Songdej, Liying Guan, et al.
Blood|February 21, 2020
Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagationIan Johnston, Amrita Sarkar, Vincent Hayes, et al.
Blood|July 15, 2016
The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)Sanjay Khandelwal, Grace M Lee, C Garren Hester, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Modulation of ultralarge immune complexes in heparin-induced thrombocytopeniaZheng Cai, Khalil Bdeir, Serge V Yarovoi, et al.
The Journal of Biological Chemistry|December 6, 2002
Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cellsTaher Nassar, Bruce S Sachais, Sa'ed Akkawi, et al.
Blood|June 17, 2020
RGS10 and RGS18 differentially limit platelet activation, promote platelet production, and prolong platelet survivalDaniel DeHelian, Shuchi Gupta, Jie Wu, et al.
Blood|April 21, 2026
PF4/Heparin-Nonbinding Platelet-Activating Antibodies in Heparin-Induced ThrombocytopeniaLu Zhou, Andrew Cao, Wen Zhu, et al.
Blood Advances|March 31, 2018
2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopeniaElizabeth Tkaczynski, Abinaya Arulselvan, John Tkaczynski, et al.
Blood Advances|May 17, 2023
Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?Amrita Sarkar, Sanjay Khandelwal, Gavin T Koma, et al.
Nature Communications|January 23, 2020
Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasisBrian D Adair, José L Alonso, Johannes van Agthoven, et al.
Pageof 17